| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/17/2005 | WO2005014825A2 Methods of protein production in yeast |
| 02/17/2005 | WO2005014824A1 Caev-based vector systems |
| 02/17/2005 | WO2005014822A2 Novel therapeutic fusion proteins |
| 02/17/2005 | WO2005014821A1 Cephalosporin c acylase mutant and method for preparing 7-aca using same |
| 02/17/2005 | WO2005014820A1 5-enolpyruvyl-3-phosphoshikimate synthase of high glyphosate-bioresistance and coding sequence |
| 02/17/2005 | WO2005014819A1 Esophageal cancer antigen and utilization thereof |
| 02/17/2005 | WO2005014818A1 Gene overexpressed in cancer |
| 02/17/2005 | WO2005014817A2 Chordin-like homologs |
| 02/17/2005 | WO2005014816A1 Antigens for immunocontraception |
| 02/17/2005 | WO2005014815A1 siRNA BASED METHODS FOR TREATING ALZHEIMER’S DISEASE |
| 02/17/2005 | WO2005014814A2 5’-and 3’-capped aptamers and uses therefor |
| 02/17/2005 | WO2005014812A2 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia |
| 02/17/2005 | WO2005014811A2 RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/17/2005 | WO2005014810A1 Efficient process for producing dumbbell dna |
| 02/17/2005 | WO2005014809A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 02/17/2005 | WO2005014807A2 Moss expressing promoting regions |
| 02/17/2005 | WO2005014806A2 Conserved hbv and hcv sequences useful for gene silencing |
| 02/17/2005 | WO2005014802A1 Method for culturing avian spermatogonial stem cells and avian spermatogonial stem cells prepared thereby |
| 02/17/2005 | WO2005014796A2 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/17/2005 | WO2005014795A2 Osteoarthritis biomarkers and uses thereof |
| 02/17/2005 | WO2005014794A2 Generation of low phytate plants by molecular disruption of inositol polyphosphate kinases |
| 02/17/2005 | WO2005014791A2 Methods and compositions for targeted cleavage and recombination |
| 02/17/2005 | WO2005014790A2 Polypeptides having oxaloecetate hydrolase activity and polynucleotides encoding same |
| 02/17/2005 | WO2005014787A2 Genetic elements conferring flower petal-specific transgene expression |
| 02/17/2005 | WO2005014786A2 Enhanced engineered chromosome formation from alpha satellite with artificially increased density of cenp-b boxes |
| 02/17/2005 | WO2005014782A2 Double-stranded ribonucleic acid with increased effectiveness in an organism |
| 02/17/2005 | WO2005014779A2 Cyclodextrin affinity purification |
| 02/17/2005 | WO2005014777A2 Methods and compositions for increasing the efficacy of biologically-active ingredients |
| 02/17/2005 | WO2005014775A2 Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a |
| 02/17/2005 | WO2005014653A2 Humanized chicken antibodies |
| 02/17/2005 | WO2005014651A1 Sugar chain-modified anti-hm1.24 antibody |
| 02/17/2005 | WO2005014645A2 Pedf-r receptor and uses |
| 02/17/2005 | WO2005014638A2 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family |
| 02/17/2005 | WO2005014635A2 Secreted polypeptide species reduced in cardiovascular disorders |
| 02/17/2005 | WO2005014634A1 A gene and uses therefor |
| 02/17/2005 | WO2005014633A1 Fluorescent protein |
| 02/17/2005 | WO2005014631A1 Fungus resistant plants and their uses |
| 02/17/2005 | WO2005014626A2 Recombinant human metapneumovirus and its use |
| 02/17/2005 | WO2005014610A1 Nucleoside capable of releasing functional unit through oxidation and process for producing oligonucleotide containing the same |
| 02/17/2005 | WO2005014607A2 Antisense modulation of stearoyl-coa desaturase expression |
| 02/17/2005 | WO2005014039A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases |
| 02/17/2005 | WO2005014022A1 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 02/17/2005 | WO2005014011A1 Use of smad 7 antisense oligonucleotides (odn) for the treatment of diseases mediated by the nuclear transcription factor nf-kb |
| 02/17/2005 | WO2005013918A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 02/17/2005 | WO2005013903A2 Derivatives of substituted quinone and uses thereof |
| 02/17/2005 | WO2005013901A2 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 02/17/2005 | WO2005013899A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | WO2005013889A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | WO2005013886A2 Methods for treating and preventing apoptosis-related diseases using rna interfering agents |
| 02/17/2005 | WO2005013802A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | WO2005013682A2 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | WO2005013680A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 02/17/2005 | WO2005013679A1 Reproductive and non-reproductive cloning method |
| 02/17/2005 | WO2004113547A3 Potent combinations of mrna transport elements |
| 02/17/2005 | WO2004106369A3 Complement inhibitors from ticks |
| 02/17/2005 | WO2004092396A3 Flap endonuclease 1 (fen1) regulatory sequences and uses thereof |
| 02/17/2005 | WO2004089072A8 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 02/17/2005 | WO2004083440A8 Modified ppase expression in sugar beet |
| 02/17/2005 | WO2004083427A3 Ligational encoding of small molecules |
| 02/17/2005 | WO2004083398A3 Therapeutic uses of hmgn1 and hmgn2 |
| 02/17/2005 | WO2004081189A9 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and organisms |
| 02/17/2005 | WO2004081046A3 Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| 02/17/2005 | WO2004072249A3 Polyvinylethers for delivery of polynucleotides to mammalian cells |
| 02/17/2005 | WO2004069991A3 Oligomeric compounds for the modulation of survivin expression |
| 02/17/2005 | WO2004065600A3 Rna interference by palindromic or modified rna molecules |
| 02/17/2005 | WO2004060277A3 Process for purification of plasmid dna |
| 02/17/2005 | WO2004060056A3 Sperm-induced cellular activation |
| 02/17/2005 | WO2004058976A3 Borrelidin-producing polyketide synthase and its use |
| 02/17/2005 | WO2004054350A3 Generation of plants with altered oil content |
| 02/17/2005 | WO2004053453A3 Modulation of bub 1-beta expression |
| 02/17/2005 | WO2004047740A3 Composition and method for treating lupus nephritis |
| 02/17/2005 | WO2004046310A3 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 02/17/2005 | WO2004044226A3 Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
| 02/17/2005 | WO2004035734A3 Plastid transformation |
| 02/17/2005 | WO2004033471A3 Glucose transport mutants for production of biomaterial |
| 02/17/2005 | WO2004016805A3 Immunostimulatory nucleic acids |
| 02/17/2005 | WO2004003820A8 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer |
| 02/17/2005 | WO2003104412A3 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects |
| 02/17/2005 | WO2003102214A3 Method for efficient rna interference in mammalian cells |
| 02/17/2005 | WO2003101396A3 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/17/2005 | WO2003070916A3 Dna encoding snorf44 receptor |
| 02/17/2005 | WO2003070910A3 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | WO2003050246A3 Antisense modulation of nod1 expression |
| 02/17/2005 | WO2003034813A3 Synthetic herbicide resistance gene |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2003004681A3 Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon |
| 02/17/2005 | WO2002101013A3 A biological method for the production of alpha-methylene-gamma-butyrolactone and its intermediates |
| 02/17/2005 | WO2002083714A3 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050039235 Transforming plant with expression vector comprising regulatory nucleotide sequences and gene sequences associated with expression if insulin in endoplasmic reticulum of flax, safflower and/or arabidopsis |
| 02/17/2005 | US20050039234 Expression vector comprising nucleotide sequences coding desaturase for use in increasing/decreasing palmitoleic acid and/or vaccenic acid concentrations in seed |
| 02/17/2005 | US20050039233 High oleic acid Brassica juncea |
| 02/17/2005 | US20050039232 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses |
| 02/17/2005 | US20050039231 Method for selecting transformed plant cells using ethionine and cystathionine gamma synthase as the selection agent and marker gene |
| 02/17/2005 | US20050039230 Nucleic acid sequences capable of improving homologous recombination in plants and plant plastids |
| 02/17/2005 | US20050039229 Double recoverable block of function |
| 02/17/2005 | US20050039228 Methods and compositions for analysis of plant gene function |
| 02/17/2005 | US20050039227 Nucleic acid encoding GAI gene of Arabidopsis thaliana |
| 02/17/2005 | US20050039226 Expression vector comprising nucleotide sequences for conferring insect resistance to a plant; transgenic insect resistant maize |